Ceftazidime – Injection products
Recognized Interpretive Criteria
Exceptions to the recognized standard of CLSI M100
|
|
Minimum Inhibitory |
Disk Diffusion |
||||
|---|---|---|---|---|---|---|
|
Pathogen |
S |
I |
R |
S |
I |
R |
|
Enterobacterales |
M100 standard is recognized |
|||||
|
Pseudomonas aeruginosa a |
≤ 8 |
- |
≥ 16 |
≥ 18 |
- |
≤ 17 |
|
Acinetobacter spp. |
M100 standard is recognized |
- |
- |
- |
||
|
Burkholderia cepacia |
M100 standard is recognized |
- |
- |
- |
||
|
Stenotrophomonas |
M100 standard is recognized |
- |
- |
- |
||
|
Haemophilus influenzae and |
M100 standard is recognized |
|||||
S = Susceptible; I = Intermediate; R = Resistant
a For P. aeruginosa, susceptibility interpretive criteria are based on a dose of 2 grams IV every 8 hours in patients with normal renal function
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Acinetobacter spp. disk diffusion interpretive criteria (Interpretive criteria for MIC are recognized.)
Burkholderia cepacia complex disk diffusion interpretive criteria (Interpretive criteria for MIC are recognized.)
Other Non-Enterobacterales